Autopsy report · NCT03624608

Evaluation of the Auryzon Devices in the Optimization of Ear and Nose Reconstruction Procedures

“Enrollment target not reached.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 7 months before it started.
• Ran for about 4 years 11 months before it stopped.
• 2 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Reconstrata, LLC

Sponsor type

Industry

Conditions

Ear Deformities, Acquired; Ear; Deformity, Congenital; Microtia; Nose Deformity; Nose Deformities, Acquired; Nose; Deformity, Congenital

Interventions

AuryzoN Family of Devices

Participants

2

Sites

1

Countries

United States

Trials that died the same way

• Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)
  “unable to meet the target enrollment goal” (83% match in meaning)
• Study on the Impact of Patient Navigators on the Health Education and Quality of Life in Formerly Incarcerated Patients
  “Target sample size not reached for enrollment.” (82% match in meaning)
• The "Peripheral Access Utilizing Sonographic Evaluation" Study
  “No enrollment was achieved” (79% match in meaning)
• Pilot Study to Evaluate Ear Acupressure Effects in Treating Seasonal Allergic Rhinitis
  “Target enrollment not met within specific time period.” (77% match in meaning)
• Comminuted Intra-Articular Distal Tibia Fracture Fixation Using Computer Techniques
  “Enrollment goal was not met.” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.